How do you make a universal flu vaccine? A microbiologist explains

Success of mRNA vaccines for COVID-19 shows promise for their use in achieving the vision of an effective universal influenza vaccine

Why the Oxford AstraZeneca vaccine is now a global game changer

There were no cases of severe COVID-19 in those who received the vaccine. And it seems to generate a protective immune response in older people

ICMR, central drug regulator admit COVID-19 vaccine side effects; health ministry rubbishes claim

Government called revelations ‘ill-informed & erroneous’

The 'vaccinegate' of Italy

A study in Italy has found major contaminants in vaccines that are used the world over

India develops first indigenous vaccine to treat bloody dysentry

Shigellosis is recognised as a disease mainly affecting Asian and African nations

Vaccine hesitancy on the rise across the globe, reveals cross-country survey

India bucks the trend; Afghanistan, Indonesia, Pakistan, the Philippines, South Korea major concerns

Self-sufficient Africa: Rwanda gets continent’s first unit for mRNA vaccine production

Containers of mRNA mobile factories called Biontainers to boost African vaccine production

Low trust in authorities affects vaccine uptake: Evidence from 22 African countries

Nearly half of the world’s unvaccinated and under-vaccinated children live in Africa

Moderna claims 94% efficacy for its COVID-19 vaccine, to seek emergency nod

No Indian partner yet for production or distribution; results not final

Missed vaccine shots: Go for innovative strategies to address zero-dose, say experts

Beyond being at risk, children who have not received a vaccine of any kind also become a population that harbours diseases and can transmit …

We’re entering a new phase of COVID, where we each have to assess and mitigate our own risk. But how?

COVID vaccines aren’t perfect and don’t completely stop transmission, but they greatly reduce your likelihood of becoming …

Vaccine inequity: Disparity in access to doses hits low-income countries, says WHO

Only 2 manufacturers are supplying key vaccines such as pneumococcal vaccines, measles and rubella-containing vaccines across the world

Burundi reports polio outbreak for the first time in 30 years

The vaccine-linked virus was detected in 3 children and 5 wastewater samples

COVID-19 vaccine update: Can boosters stave off new variants in India as cases rise?

CoWIN platform doesn’t allow registration for a fourth COVID-19 vaccine dose so far 

Want to know about COVID-19 vaccine rollouts in Africa? Click on a country here and find out

In the 29 low-income countries, only 3 out of 100 people have received one dose of the vaccine 

Katalin Karikó and the innovation issue

Rockstar scientist Kariko’s obsessive research of mRNA has prompted NYT to say she ‘helped shield the world from the coronavirus&…

Did Punjab introduce cancer vaccine based on faulty research by PGI Chandigarh?

Claims made by the professors at PGIMER have been challenged by a member of the National Technical Advisory Group on Immunisation

COVID-19: Extensive research underway; how much will it help?

As many as 42 vaccines were in preclinical stage and two vaccines in Phase I clinical trials as of March 20, according to WHO  

Expert committee recommends emergency approval for Sputnik V COVID-19 vaccine in India

Dr Reddy’s to import initial doses; domestic production to start in the country in a few months

Measles: Zimbabwe launches awareness campaign to fight vaccine hesitancy

This follows a sharp uptick in caseload and deaths  

COVID-19 vaccination has turned into a ‘battle of the brands’. But not everyone’s buying it

The best thing we can do is to tone down the brand narrative within the significant constraints we face. All COVID-19 vaccines are safe and effective

108th Indian Science Congress: Research needed to ensure carbon capture tech is efficient, experts say

Directly Observed Short Course Therapy, vaccination can make India TB-free

Race to procure COVID-19 vaccine doses: Where do countries stand?

India has confirmed the maximum number of doses at 1.6 billion

WHO adopts plan to make vaccines cheaper and more accessible

Calls for transparency around vaccine pricing and procurement

COVID-19 vaccine development: It’s a relay race

The reason trials are taking shorter time is because developers are taking more risks